Rick Strassman
There is a high rate of DMT users reporting contact with alien-like beings. The fact that users have reported this taps into extra-terrestial scenarios but also it is the first time a psychedelic is having such a unanimous effect on a wide base of users. Rick Strassman talks about the effects of DMT and has a closer look in the pharmaceutical and psychedelic aspect. Peer-Reviewed Journal Articles1. Strassman RJ, Letourneau P, Wessells NK: Elongation of axons in an agar matrix that does not support cell locomotion. Experimental Cell Research 818:482-487, 19732. Strassman Rick J, Wessells NK: Orientational preferences shown by microspikes of growing nerve cells in vitro. Tissue and Cell 5:412-417, 1973 3. Strassman Rick J, Galanter M: The Abhidharma: A cross-cultural application of meditation. International Journal of Social Psychiatry 26:283-290, 1980 4. Risch SC, Janowsky DS, Lisansky EJ, Strassman Rick J, Rausch JL, Gillin JC, Judd LL, Huey L: Dexamethasone effects on self-rated mood in depressed inpatients. American Journal of Psychiatry 141:147-148, 1984 5. Strassman Rick J: Adverse reactions to psychedelic drugs: A review of the literature. Journal of Nervous and Mental Disease 172:577-595, 1984 6. Greer G, Strassman RJ: Information on "Ecstasy." (letter) American Journal of Psychiatry 142:1391, 1985 7. Strassman Rick: Light, season, and affective disorders. Western Journal of Medicine 142:678, 1985 8. Kennedy B, Strassman RJ, Ziegler M, Janowsky DS, Risch SC, Huey L, Gillin JC: Cardiovascular, catecholamine and psychological responses to TRH in four types of affective disorder patients. Hormone and Metabolic Research 19:164-167, 1987 9. Strassman RJ, Peake GT, Qualls CR, Lisansky EJ: A model for the study of the acute effects of melatonin in man. Journal of Clinical Endocrinology and Metabolism 65:847-852, 1987 10. Rosenthal M, Strassman RJ: Melatonin does not impair corticotropin response of isolated pituitary cells. Neuroendocrinology Letters 10:27-32, 1988 11. Strassman RJ, Peake GT, Qualls CR, Lisansky EJ: Lack of an acute modulatory effect of melatonin on human nocturnal thyrotropin and cortisol secretion. Neuroendocrinology 48:387-393, 1988 12. Strassman RJ, Appenzeller O, Lewy AJ, Qualls CR, Peake GT: Increase in plasma melatonin, beta-endorphin and cortisol after a high-altitude mountain run. Relationship to performance and lack of an effect of naltrexone. Journal of Clinical Endocrinology and Metabolism 69:540-545, 1989 13. Lisansky EJ, Peake GT, Strassman RJ, Qualls CR, Meikle AW, Risch SC, Fava G, Zownir-Brazis M, Hochla P, Britton D: Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pre-treated with metyrapone. Archives of General Psychiatry 46:641-649, 1989 14. Strassman Rick, Qualls CR, Lisansky EJ, Peake GT: Sleep deprivation reduces LH secretion independently of melatonin. Acta Endocrinologica (Scandinavica) 124:646-651, 1991 15. Strassman RJ, Qualls CR, Lisansky EJ, Peake GT: Elevated rectal temperature produced by all night bright light is reversed by melatonin infusion in men. Journal of Applied Physiology 71:2178-2182, 1991 16. Strassman RJ: Human hallucinogenic drug research in the United States: A present-day case history and a review of the process. Journal of Psychoactive Drugs 23:29-38, 1991 17. Rick Strassman: Human hallucinogen interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacology 7:241-243; 1992 18. Lisansky EJ, Hauger R, Strassman RJ, Dorin R, Meikle AW, Brazis M, Qualls CR, Turkin A. Beta-endorphin response to a low dosage of human corticotropin releasing hormone during metyrapone administration in depression. Endocrine Research. 18:241-260, 1992. 19. Strassman RJ, Qualls CR. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic and cardiovascular effects. Archives of General Psychiatry. 51:85-97, 1994. 20. Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry. 51:98-108, 1994. 21. Strassman RJ. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects. Journal of Nervous and Mental Disease. 183:127-138, 1995. 22. Strassman RJ. Human psychopharmacology of N,N-dimethyltryptamine. Behavioral Brain Research. 73:121-124, 1996. 23. Grob C, McKenna D, Callaway J, Brito G, Neves E, Oberlaender G, Saide O, Labigalini E, Tacla C, Miranda C, Strassman R, Boone K. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease. 184: 86-94, 1996 24. Strassman RJ, Qualls C, Berg LM. Differential tolerance development to biological and subjective effects of four closely-spaced administrations of N,N-dimethyltryptamine in humans. Biological Psychiatry 39:784-795, 1996 25. Strassman RJ. Endogenous ketamine-like compounds and the NDE: If so, so what? Journal of Near-Death Studies 16:27-42, 1997 26. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in normal volunteers: Relationship to steady-state plasma concentrations. Anesthesiology 88:82-88, 1998 27. Riba J, Rodriguez-Fornelis A, Strassman RJ, Barbanoj M J. Psychometric assessment of the Hallucinogen Rating Scale in two different populations of hallucinogen users. Drug and Alcohol Dependence 62:215-223, 2001 28. Krupitsky EM, Burakov AM, Romanov TN, Grinenko AY, Strassman RJ. Ketamine-assisted psychotherapy (KPT) of heroin addiction: Immediate effects and six month follow-up. Heffter Review of Psychedelic Research 2:88-101, 2001 29. Krupitsky EM, Burakov AM, Romanov TN, Dunaevksy I, Strassman RJ, Grinenko AY. Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up. Journal of Substance Abuse Treatment (in press) |
